worldwide sites | stay connected | contact | help | sitemap







Fact sheet 2007
| Chairman and CEO |
Daniel Vasella, M.D. |
| Headquarters |
Basel, Switzerland |
| Major R&D sites |
Basel, Switzerland |
| |
Cambridge, Massachusetts |
| |
East Hanover, New Jersey |
| |
Horsham, England |
| |
Shanghai, China |
| Major production sites |
Basel, Schweizerhalle and Stein, Switzerland |
| |
Grimsby, UK |
| |
Huningue, France |
| |
Kundl and Schaftenau, Austria |
| |
Kurtkoy, Turkey |
| |
Nyon, Switzerland |
| |
Ringaskiddy, Ireland |
| |
Singapore |
| |
Suffern, New York, US |
| Web site address |
www.novartis.com |
| Stock exchange listings |
Switzerland (virt-x) |
| |
New York Stock Exchange |
| |
London Stock Exchange |
| 2007 sales |
USD 38.1 billion |
| Pharmaceuticals |
USD 24.0 billion |
| Vaccines and Diagnostics |
USD 1.5 million |
| Sandoz |
USD 7.2 billion |
| Consumer Health |
USD 5.4 billion |
| 2007 R&D spending |
USD 6.4 billion |
| Pharmaceuticals |
USD 5.1 billion |
| Vaccines and Diagnostics |
USD 295 million |
| Sandoz |
USD 563 million |
| Consumer Health |
USD 301 million |
| Corporate |
USD 183 million |
| Full-time associates (2007) |
98 200 |
| Pharmaceuticals |
54 613 |
| Vaccines and Diagnostics |
4 810 |
| Sandoz |
23 087 |
| Consumer Health |
13 956 |
| Corporate |
1 734 |
Get Novartis Media Releases through RSS
Stay Connected
Novartis milestones
Innovative medicines